BR9711093A - Derivados selecionados de k-252a - Google Patents
Derivados selecionados de k-252aInfo
- Publication number
- BR9711093A BR9711093A BR9711093A BR9711093A BR9711093A BR 9711093 A BR9711093 A BR 9711093A BR 9711093 A BR9711093 A BR 9711093A BR 9711093 A BR9711093 A BR 9711093A BR 9711093 A BR9711093 A BR 9711093A
- Authority
- BR
- Brazil
- Prior art keywords
- selected derivatives
- survival
- enhancing
- compounds
- represented
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65736696A | 1996-06-03 | 1996-06-03 | |
PCT/US1997/009448 WO1997046565A1 (en) | 1996-06-03 | 1997-06-02 | SELECTED DERIVATIVES OF K-252a |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9711093A true BR9711093A (pt) | 1999-08-17 |
Family
ID=24636859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9711093A BR9711093A (pt) | 1996-06-03 | 1997-06-02 | Derivados selecionados de k-252a |
Country Status (18)
Country | Link |
---|---|
US (1) | US6306849B1 (pt) |
EP (1) | EP0918777B1 (pt) |
JP (1) | JP2000511902A (pt) |
CN (1) | CN1198827C (pt) |
AT (1) | ATE222912T1 (pt) |
AU (1) | AU716656B2 (pt) |
BR (1) | BR9711093A (pt) |
CA (1) | CA2256633C (pt) |
DE (1) | DE69715010T2 (pt) |
DK (1) | DK0918777T3 (pt) |
ES (1) | ES2183184T3 (pt) |
HK (1) | HK1018703A1 (pt) |
NO (1) | NO312464B1 (pt) |
NZ (2) | NZ333018A (pt) |
PT (1) | PT918777E (pt) |
RU (1) | RU2205184C2 (pt) |
UA (1) | UA67725C2 (pt) |
WO (1) | WO1997046565A1 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7795246B2 (en) | 1998-08-06 | 2010-09-14 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
US6200968B1 (en) | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
EP1126855B1 (en) | 1998-09-25 | 2007-05-09 | Cephalon, Inc. | Use of fused pyrrolocarbazoles for preventing/treating damage to sensory hair cells and cochlear neurons |
US7129250B2 (en) | 2000-05-19 | 2006-10-31 | Aegera Therapeutics Inc. | Neuroprotective and anti-proliferative compounds |
US7018999B2 (en) | 2001-05-16 | 2006-03-28 | Cephalon, Inc. | Methods for the treatment and prevention of pain |
WO2004016167A1 (en) * | 2002-08-16 | 2004-02-26 | The General Hospital Corporation | Non-invasive functional imaging of peripheral nervous system activation in humans and animals |
CA2500901A1 (en) * | 2002-10-04 | 2004-04-22 | Rinat Neuroscience Corp. | Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists |
UA80447C2 (en) | 2002-10-08 | 2007-09-25 | Methods for treating pain by administering nerve growth factor antagonist and opioid analgesic | |
AU2003304238A1 (en) * | 2002-10-08 | 2005-01-13 | Rinat Neuroscience Corp. | Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same |
MXPA05003502A (es) * | 2002-10-08 | 2005-09-30 | Rinat Neuroscience Corp | Metodo para tratar dolor post-quirurgico al administrar un antagonista del factor de crecimiento de nervios y composiciones que contienen el mismo. |
NZ540730A (en) * | 2002-12-24 | 2010-09-30 | Rinat Neuroscience Corp | Anti-NGF antibodies and methods using same |
US7569364B2 (en) | 2002-12-24 | 2009-08-04 | Pfizer Inc. | Anti-NGF antibodies and methods using same |
US9498530B2 (en) | 2002-12-24 | 2016-11-22 | Rinat Neuroscience Corp. | Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same |
ATE491444T1 (de) * | 2003-02-19 | 2011-01-15 | Rinat Neuroscience Corp | Verfahren zur behandlung von schmerzen durch verabreichung eines nervenwachstumsfaktor- antagonisten und eines nsaid und diese enthaltende zusammensetzung |
US20060014165A1 (en) * | 2003-07-14 | 2006-01-19 | Decode Genetics Ehf. | Methods of diagnosis and treatment for asthma and other respiratory diseases based on haplotype association |
KR101504729B1 (ko) | 2004-04-07 | 2015-03-19 | 리나트 뉴로사이언스 코프. | 신경성장인자 길항제의 투여에 의한 골암 통증 치료용 약학적 조성물 |
MX2007001155A (es) * | 2004-07-29 | 2007-08-14 | Creabilis Therapeutics Spa | Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1. |
US20080021013A1 (en) * | 2006-07-21 | 2008-01-24 | Cephalon, Inc. | JAK inhibitors for treatment of myeloproliferative disorders |
DK2381964T3 (da) * | 2008-12-22 | 2014-09-29 | Creabilis S A | Syntese af polymerkonjugater af indolocarbazolforbindelser |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4554402A (en) | 1983-12-23 | 1985-11-19 | Aluminum Company Of America | Vibration damper for overhead conductor |
JPS62120388A (ja) | 1985-11-19 | 1987-06-01 | Meiji Seika Kaisha Ltd | Sf−2370物質ハロゲン化誘導体とその製造法 |
JPS62155284A (ja) | 1985-12-27 | 1987-07-10 | Kyowa Hakko Kogyo Co Ltd | 生理活性物質k−252の誘導体 |
JPS62155285A (ja) | 1985-12-27 | 1987-07-10 | Kyowa Hakko Kogyo Co Ltd | 生理活性物質k−252の誘導体 |
JPS62220196A (ja) | 1986-03-20 | 1987-09-28 | Kyowa Hakko Kogyo Co Ltd | 新規物質ucn―01 |
US4816450A (en) | 1986-09-15 | 1989-03-28 | Duke University | Inhibition of protein kinase C by long-chain bases |
JPH0826036B2 (ja) * | 1987-01-22 | 1996-03-13 | 協和醗酵工業株式会社 | 生理活性物質k−252の誘導体 |
JPH0826037B2 (ja) | 1987-01-22 | 1996-03-13 | 協和醗酵工業株式会社 | 生理活性物質k−252の誘導体 |
US4735939A (en) | 1987-02-27 | 1988-04-05 | The Dow Chemical Company | Insecticidal activity of staurosporine |
WO1988007045A1 (en) | 1987-03-09 | 1988-09-22 | Kyowa Hakko Kogyo Co., Ltd. | Derivatives of physiologically active substance k-252 |
IL86632A0 (en) | 1987-06-15 | 1988-11-30 | Ciba Geigy Ag | Derivatives substituted at methyl-amino nitrogen |
US5093330A (en) | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
JPH07113027B2 (ja) | 1987-12-24 | 1995-12-06 | 協和醗酵工業株式会社 | K−252誘導体 |
JP2766360B2 (ja) | 1988-02-04 | 1998-06-18 | 協和醗酵工業株式会社 | スタウロスポリン誘導体 |
DE3835842A1 (de) | 1988-10-21 | 1990-04-26 | Goedecke Ag | Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel |
DE3924538A1 (de) | 1989-07-25 | 1991-01-31 | Goedecke Ag | Indolocarbazol und dessen verwendung |
AU7035991A (en) | 1989-12-14 | 1991-07-18 | Schering Corporation | Indolocarbazoles from saccharothrix aerocolonigenes subsp. copiosa subsp. nov. scc 1951 atcc 53856 |
JPH0586068A (ja) | 1991-03-04 | 1993-04-06 | Rikagaku Kenkyusho | 新規抗生物質rk−1409、その製造法並びに抗腫瘍剤及び抗炎症剤 |
CA2123096A1 (en) | 1991-11-08 | 1993-05-13 | Beat J. Knusel | Compositions containing k-252 compounds for potentiation of neurotrophin activity |
JP2593021B2 (ja) | 1991-12-13 | 1997-03-19 | 伊藤ハム株式会社 | ウシ胚の性の識別方法 |
US6271242B1 (en) | 1992-02-10 | 2001-08-07 | Bristol-Myers Squibb Co. | Method for treating cancer using a tyrosine protein kinase inhibitor |
JPH05247055A (ja) | 1992-03-03 | 1993-09-24 | Meiji Seika Kaisha Ltd | スタウロスポリン誘導体及びそれを含有する抗腫瘍効果増強剤 |
DE69326388T2 (de) | 1992-06-22 | 1999-12-30 | Kyowa Hakko Kogyo Kk | Verfahren zur Herstellung von Staurosporin-Derivaten |
JPH0673063A (ja) | 1992-06-22 | 1994-03-15 | Kyowa Hakko Kogyo Co Ltd | Ucn−01誘導体 |
US5621100A (en) | 1992-07-24 | 1997-04-15 | Cephalon, Inc. | K-252a derivatives for treatment of neurological disorders |
US5461146A (en) | 1992-07-24 | 1995-10-24 | Cephalon, Inc. | Selected protein kinase inhibitors for the treatment of neurological disorders |
DE69331228D1 (en) * | 1992-09-21 | 2002-01-10 | Kyowa Hakko Kogyo Kk | Heilmittel für thrombozytopenia |
ES2118414T3 (es) | 1993-05-28 | 1998-09-16 | Cephalon Inc | Utilizacion de derivados del indolocarbazol para el tratamiento de la prostata. |
EP0703917A1 (en) | 1993-06-17 | 1996-04-03 | Novartis AG | Indolocarbazole compound useful as proteinkinase c inhibitor |
US5468872A (en) | 1993-09-16 | 1995-11-21 | Cephalon, Inc. | K-252a functional derivatives potentiate neurotrophin-3 for the treatment of neurological disorders |
-
1997
- 1997-02-06 UA UA98126949A patent/UA67725C2/uk unknown
- 1997-06-02 BR BR9711093A patent/BR9711093A/pt active Search and Examination
- 1997-06-02 WO PCT/US1997/009448 patent/WO1997046565A1/en active IP Right Grant
- 1997-06-02 AU AU32253/97A patent/AU716656B2/en not_active Ceased
- 1997-06-02 DK DK97927906T patent/DK0918777T3/da active
- 1997-06-02 RU RU99100050/04A patent/RU2205184C2/ru not_active IP Right Cessation
- 1997-06-02 NZ NZ333018A patent/NZ333018A/xx not_active IP Right Cessation
- 1997-06-02 ES ES97927906T patent/ES2183184T3/es not_active Expired - Lifetime
- 1997-06-02 CN CNB97196985XA patent/CN1198827C/zh not_active Expired - Fee Related
- 1997-06-02 AT AT97927906T patent/ATE222912T1/de not_active IP Right Cessation
- 1997-06-02 JP JP10500751A patent/JP2000511902A/ja active Pending
- 1997-06-02 EP EP97927906A patent/EP0918777B1/en not_active Expired - Lifetime
- 1997-06-02 US US08/867,084 patent/US6306849B1/en not_active Expired - Fee Related
- 1997-06-02 CA CA002256633A patent/CA2256633C/en not_active Expired - Fee Related
- 1997-06-02 PT PT97927906T patent/PT918777E/pt unknown
- 1997-06-02 DE DE69715010T patent/DE69715010T2/de not_active Expired - Lifetime
-
1998
- 1998-12-02 NO NO19985622A patent/NO312464B1/no not_active IP Right Cessation
-
1999
- 1999-08-31 HK HK99103763A patent/HK1018703A1/xx not_active IP Right Cessation
-
2000
- 2000-04-19 NZ NZ504097A patent/NZ504097A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1198827C (zh) | 2005-04-27 |
AU716656B2 (en) | 2000-03-02 |
WO1997046565A1 (en) | 1997-12-11 |
NO985622D0 (no) | 1998-12-02 |
CA2256633A1 (en) | 1997-12-11 |
CN1226893A (zh) | 1999-08-25 |
ATE222912T1 (de) | 2002-09-15 |
AU3225397A (en) | 1998-01-05 |
RU2205184C2 (ru) | 2003-05-27 |
NZ333018A (en) | 2000-05-26 |
NO985622L (no) | 1999-02-02 |
DE69715010T2 (de) | 2003-04-03 |
PT918777E (pt) | 2003-01-31 |
NO312464B1 (no) | 2002-05-13 |
EP0918777A1 (en) | 1999-06-02 |
HK1018703A1 (en) | 1999-12-30 |
JP2000511902A (ja) | 2000-09-12 |
CA2256633C (en) | 2009-04-07 |
NZ504097A (en) | 2005-06-24 |
DE69715010D1 (de) | 2002-10-02 |
UA67725C2 (en) | 2004-07-15 |
ES2183184T3 (es) | 2003-03-16 |
EP0918777B1 (en) | 2002-08-28 |
US6306849B1 (en) | 2001-10-23 |
DK0918777T3 (da) | 2002-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9711093A (pt) | Derivados selecionados de k-252a | |
MX9702682A (es) | Pirrolocarbazoles fusionados. | |
EP0630898A4 (en) | MEDICINE FOR THROMBOZYTOPENIA. | |
MY126559A (en) | Fungicidal 2-methoxybenzophenones | |
ES2187660T3 (es) | Derivados de rapamicina. | |
ES8400438A1 (es) | Procedimiento para preparar derivados de (3h)-imidazo(5,1-d)-1,2,3,5-tetrazin-4-ona. | |
EP0721942A4 (en) | NEW TETRACYCLIC COMPOUND | |
IE780922L (en) | 1,3,5-s-HEXAHYDROSUBSTITUTED TRIAZINES | |
WO1998018466A3 (en) | Anti-neurogenic inflammatory compounds and compositions and methods of use thereof | |
ATE234308T1 (de) | 3'-epi k-252a derivate | |
AU578489B2 (en) | Proline derivatives | |
DE69703115D1 (de) | Zwischenprodukte um 2-imidazolin-5onederivate herzustellen. | |
AU7020996A (en) | UCK14 compounds | |
GB9911556D0 (en) | Immunosuppressant tricyclic compounds | |
CA2201219A1 (en) | Process for the preparation of substituted pyrimidines | |
DK0566557T3 (da) | 2- og 3-amino- og azidoderivater af 1,5- iminosukkere som antivirale forbindelser | |
SU1746666A1 (ru) | Замещенные 3-аминометиленпирролидин-2,4-дионы, обладающие противосудорожной активностью |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO COM BASE NOS ARTIGOS 10(VIII), 24 E 25 DA LEI 9.279/96 |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |